The Lasseigne Lab uses genomic strategies and data to study complex and rare diseases with the goal of discovering biological signatures that might be used to improve patient care and provide insight into molecular processes contributing to disease. We currently have active collaborations in cancer, neurodegeneration, kidney, and rare disease projects.
Context of disease manifestations
Identification of causal variants and genes in cancer, neurodegenerative, and rare diseases
Drug target and repurposing prioritization
Developing computational tools to share with the research community
MULTIOMICS ASSAY AND ANALYTICAL APPROACHES
Discovery of cancer (e.g., kidney, GBM, prostate, etc.) diagnostic biomarkers and therapeutic signatures